Union européenne - français - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - tumeurs stromales gastro-intestinales - d'autres agents antinéoplasiques, les inhibiteurs de protéines kinases - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

blueprint medicines (switzerland) gmbh - avapritinibum - comprimés pelliculés - avapritinibum 25 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 0.271 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171, pro compresso obducto. - gastrointestinaler stromatumor (gist) und fortgeschrittene systemische mastozytose (advsm) - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

blueprint medicines (switzerland) gmbh - avapritinibum - comprimés pelliculés - avapritinibum 50 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 0.543 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171, pro compresso obducto. - gastrointestinaler stromatumor (gist) und fortgeschrittene systemische mastozytose (advsm) - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

blueprint medicines (switzerland) gmbh - avapritinibum - comprimés pelliculés - avapritinibum 100 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 1.086 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171, drucktinte: e 133, e 171, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro compresso obducto. - gastrointestinaler stromatumor (gist) und fortgeschrittene systemische mastozytose (advsm) - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

blueprint medicines (switzerland) gmbh - avapritinibum - comprimés pelliculés - avapritinibum 200 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 2.172 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171, drucktinte: e 133, e 171, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro compresso obducto. - gastrointestinaler stromatumor (gist) und fortgeschrittene systemische mastozytose (advsm) - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

blueprint medicines (switzerland) gmbh - avapritinibum - comprimés pelliculés - avapritinibum 300 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 3.257 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171, drucktinte: e 133, e 171, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro compresso obducto. - gastrointestinaler stromatumor (gist) und fortgeschrittene systemische mastozytose (advsm) - synthetika